Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03749434 · ClinicalTrials.gov registry record
Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 34,958
- Enrollment target
NCT03749434: Completed study, sponsored by University of Michigan.
NCT03749434 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 34,958 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03749434 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 34,958 participants
- Enrollment target
Study Summary
Substantial center variability exists in healthcare-associated infection (HAI) rates following durable ventricular assist device (VAD) implantation for patients with advanced heart failure. Preliminary evidence suggests that this variability may be related to process (e.g., pre-operative intranasal mupirocin), provider (e.g., surgeon technique, physician teamwork), device, (e.g., centrifugal vs. axial flow), and center specific (e.g., infection prevention strategies and resources) factors. The investigators will undertake a mixed methods study to: (1) identify determinants of center-level variability in HAI rates, (2) develop a comprehensive understanding of barriers and facilitators for achieving low center HAI rates, and (3) develop, iteratively enhance, and disseminate a best practices toolkit for preventing HAIs that accommodates various center contexts.
Primary Outcome
Any healthcare-associated infection within 90 days following a VAD implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,958 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2024-06-30 |
What the finished NCT03749434 record still lists
NCT03749434 is an observational study that tracks outcomes without assigning an intervention. Its 34,958 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03749434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03749434 about?
NCT03749434 is a clinical study titled "Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy". Substantial center variability exists in healthcare-associated infection (HAI) rates following durable ventricular assist device (VAD) implantation for patients with advanced heart failure. Preliminary evidence suggests that this variability may be related to process (e.g., pre-operative intranasal ...
What is the current status of trial NCT03749434?
This trial is currently completed. The enrollment target is 34,958 participants. The study started on 2019-02-04. Estimated completion is 2024-06-30.
Who is sponsoring clinical trial NCT03749434?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI